Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma

This is an open-label, single-arm study to treat the adult R/R Large B-cell Lymphoma subjects with Relmacabtagene autoleucel (relma-cel) in China.

Participants needed: 12
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Ming Ju Biotechnology Co., Ltd.Updated: Aug 21, 2024Locations: 1
Eligibility criteria

≥18 years old; [+10]

Primary CNS lymphoma; [+10]

Read more
Status: Not yet recruiting

Relmacabtagene Autoleucel in Hematologic Malignancies

To evaluate the efficacy and safety of Relmacabtagene Autoleucel in the treatment of adult patients with hematologic malignancies in real-world

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Shanghai Ming Ju Biotechnology Co., Ltd.Updated: Nov 21, 2023Locations: 2
Eligibility criteria

Signed informed consent [+2]

Read more